ArriVent BioPharma (AVBP) Shares Issued (2023 - 2026)

ArriVent BioPharma has disclosed Shares Issued across 4 years of filings, most recently posting $54.7 million for Q1 2026.

• Shares Issued for Q1 2026 came in at $54.7 million, up 739.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $48.7 million (down 74.69% YoY), and the FY2025 annual result was $502000.0, down 99.73% from the prior year.
• Shares Issued came in at $54.7 million for Q1 2026 at ArriVent BioPharma, up from $84000.0 in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $185.9 million in Q3 2024 to a low of -$6.1 million in Q2 2025.
• The 4-year median for Shares Issued is $46500.0 (2024), against an average of $20.1 million.
• Peak annual rise in Shares Issued reached 651500.0% in 2025, while the deepest fall reached 14070.45% in 2025.
• ArriVent BioPharma's Shares Issued stood at $285000.0 in 2023, then soared by 65129.82% to $185.9 million in 2024, then plunged by 99.95% to $84000.0 in 2025, then soared by 65047.62% to $54.7 million in 2026.
• The last three Shares Issued figures came in at $54.7 million (Q1 2026), $84000.0 (Q4 2025), and $49000.0 (Q3 2025), per Business Quant data.